Addex Therapeutics Ltd
ADXN8.990USD
-1.135-11.21%
收盘 09/19, 16:00（美东）报价延迟15分钟
7.37M总市值
0.97市盈率 TTM
关于 Addex Therapeutics Ltd 公司
Addex Therapeutics Ltd 是一家位于瑞士的临床阶段制药公司。该公司专注于开发和商业化口服小分子药物，这些药物被称为神经系统疾病的变构调节剂。该公司的临床项目包括 dipraglurant (mGlu5 NAM)，这是帕金森病左旋多巴诱发的运动障碍 (PD-LID) 的 2a 期安慰剂对照临床试验，并准备进入 PD-LID 的注册试验，以及 ADX71149 (mGlu2 正变构调节剂或 PAM)，这是由其合作伙伴 Janssen Pharmaceuticals, Inc 合作开发的，用于治疗精神分裂症和焦虑性抑郁症。它还在推进几个临床前项目，包括用于治疗疼痛、膀胱过度活动症和其他疾病的 GABABPAM、用于治疗创伤后应激障碍的 mGlu7 NAM、用于治疗轻度神经认知障碍的 mGlu2 NAM、用于治疗帕金森病的 mGlu4 PAM 和用于治疗神经退行性疾病的 mGlu3 PAM。
公司简介
公司代码ADXN
公司名称Addex Therapeutics Ltd
上市日期May 22, 2007
CEOMr. Tim Dyer
员工数量2
证券类型Ordinary Share
年结日May 22
公司地址Chemin des Mines, 9
城市PLAN-LES-OUATES
上市交易所SIX Swiss Exchange
国家Switzerland
邮编1202
电话41228841555
网址https://www.addextherapeutics.com/en/
公司代码ADXN
上市日期May 22, 2007
CEOMr. Tim Dyer
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Dr. Isaac Manke
Dr. Isaac Manke
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Roger G. Mills
Dr. Roger G. Mills
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
GAMMA Investing LLC
0.01%
其他
99.99%
持股股东
持股股东
占比
GAMMA Investing LLC
0.01%
其他
99.99%
股东类型
持股股东
占比
Research Firm
0.02%
Investment Advisor/Hedge Fund
0.01%
其他
99.97%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
12
12.04K
1.13%
-165.56K
2025Q1
16
13.11K
1.23%
-176.53K
2024Q4
17
15.10K
1.41%
-160.92K
2024Q3
22
37.43K
5.74%
-146.56K
2024Q2
21
38.45K
5.90%
-143.53K
2024Q1
20
36.44K
5.64%
-145.16K
2023Q4
19
195.87K
20.93%
+138.26K
2023Q3
18
73.39K
96.72%
+38.94K
2023Q2
18
50.23K
7.45%
-253.79K
2023Q1
17
333.00K
49.67%
+248.23K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
GAMMA Investing LLC
1.19K
0.11%
+182.00
+18.00%
Mar 31, 2025
Morgan Stanley & Co. LLC
100.00
0.01%
-1.80K
-94.74%
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
72.00
0.01%
-35.00
-32.71%
Mar 31, 2025
SBI Securities Co., Ltd.
5.00
0%
--
--
Mar 31, 2025
Citadel Advisors LLC
11.74K
1.1%
-338.00
-2.80%
Mar 31, 2025
J. Stern & Co. LLP
--
0%
-107.83K
-100.00%
Mar 31, 2024
Armistice Capital LLC
--
0%
-43.00K
-100.00%
Mar 31, 2024
Baader Bank AG
--
0%
-960.00
-100.00%
Dec 31, 2023
Jane Street Capital, L.L.C.
--
0%
-529.00
-100.00%
Dec 31, 2023
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
公告日期
类型
比率
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
Oct 06, 2023
Merger
20→1
